The complex role of B7 molecules in tumor immunology
- 31 December 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 14 (12), 550-559
- https://doi.org/10.1016/j.molmed.2008.09.010
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2008
- Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2Proceedings of the National Academy of Sciences of the United States of America, 2008
- B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease RecurrenceJournal of Urology, 2008
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeProceedings of the National Academy of Sciences of the United States of America, 2007
- Inhibitory costimulation and anti-tumor immunitySeminars in Cancer Biology, 2007
- B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survivalProceedings of the National Academy of Sciences of the United States of America, 2006
- Tissue expression of PD-L1 mediates peripheral T cell toleranceThe Journal of Experimental Medicine, 2006
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaThe Journal of Experimental Medicine, 2006
- Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinomaCancer, 2005